UNSPSC 85811528: Introduction of monoclonal antibody into pleural cavity, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into pleural cavity, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0L30M

UNSPSC 85811528 (Introduction of monoclonal antibody into pleural cavity, percutaneous approach) is a Commodity code that shows minimal recent activity aligned with its nominal scope. The code's name describes a specific medical procedure—intrathecal or intracavitary monoclonal antibody injection—but state and local governments do not appear to be procuring this service directly. Instead, the recent opportunities tagged under this code cover a much broader range of health services delivery and system operations: virtual urgent care, comprehensive occupational health, behavioral health crisis stabilization, opioid use disorder treatment, mental health counseling, cancer screening, medical examinations, nursing home operations, and employee wellness platforms. These procurement opportunities span health plans, counties, cities, state health authorities, school districts, and public-sector employers, but none reflect the specialized oncologic or pulmonary procedure the code nominally describes. The divergence between the code name and actual buying activity suggests a classification mismatch rather than active procurement under this code's true scope.

The recent opportunities are scattered across states including California, Georgia, Nevada, Colorado, Kansas, Texas, Florida, Oregon, Missouri, Virginia, and Arizona, with no geographic concentration. Representative recent solicitations include Inland Empire Health Plan (California) seeking virtual urgent care vendors via RFI (due October 31, 2026); DeKalb County, Georgia requesting medical services proposals via RFP (due November 12, 2026); and the Nevada Health Authority issuing an RFP for Program of All Inclusive Care for the Elderly (PACE) operations (due December 10, 2026). Given the absence of recent state and local procurement actually seeking monoclonal antibody services or related oncology/pulmonology interventions, this code warrants close attention only if your firm provides the broader health services the opportunities reflect—not the specialized procedure the code nominally names. Skip this code if your business focuses on the specific monoclonal antibody or pleural cavity procedure; pursue only if you operate in one of the broader service categories (virtual care, occupational health, behavioral health, wellness, EMS, or medical director services) and the geographic footprint aligns with your operations.